Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Endovascular Exclusion of Ascending and Thoracic Aortic Pathology

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2017 by The Cleveland Clinic
Sponsor:
Collaborator:
The Cleveland Clinic
Information provided by (Responsible Party):
Matthew Eagleton, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT00583817
First received: December 20, 2007
Last updated: April 12, 2017
Last verified: April 2017

December 20, 2007
April 12, 2017
May 2001
December 2020   (Final data collection date for primary outcome measure)
Freedom from aneurysm rupture [ Time Frame: 2 years ]
Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan
Saftey [ Time Frame: Undecided ]
Complete list of historical versions of study NCT00583817 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Endovascular Exclusion of Ascending and Thoracic Aortic Pathology
Endovascular Exclusion of Ascending and Thoracic Aortic Pathology
The purpose of this study is to assess the role of ascending and/or aortic arch aneurysm/dissections treatment using a novel endovascular prosthesis in high risk surgical patients.
This study is a prospective, non-randomized evaluation of ascending and thoracic pathology endovascular repair in the high-risk patient. The purpose of this study is to assess the role of the thoracic aortic pathology treatment using endovascular prosthesis in high-risk patients. The study objectives include (1) to assess the safety and efficacy of endovascular prosthesis as a means of preventing aneurysm growth and rupture in high risk patients, (2) to measure the physiologic effects and outcomes of endovascular aneurysm repair, (3) to establish selection criteria, improve device design, operative technique, and follow-up procedures for patients undergoing aneurysm repair. There will be up to 15 patients in the ascending aortic lesion arm and 20 patients in Arch Branch arm; all at one site (The Cleveland Clinic). Baseline procedures may include an angiogram, intravascular ultrasound, CT scan, chest x-ray, physical exam, blood work, and ankle-brachial index. The endovascular prosthesis is placed in the operating room under regional or general anesthesia. Follow-up evaluations may include physical exam, blood work, CT scan or MRI, chest x-ray, cardiac echo and ankle-brachial index.
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
  • Thoracic Aortic Aneurysms
  • Dissecting, Aneurysm
  • Ascending Aorta Aneurysm
  • Aortic Arch; Aneurysm, Dissecting
  • Ascending Aortic Dissection
Device: Endovascular stent-graft implantation
Endovascular repair with a research device
Other Name: Cook Zenith
  • Experimental: Ascending Aortic Arm
    Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the ascending aorta.
    Intervention: Device: Endovascular stent-graft implantation
  • Experimental: Arch Branch Arm
    Investigational endovascular stent-graft implantation to exclude aneurysm or repair dissection of the aortic arch.
    Intervention: Device: Endovascular stent-graft implantation

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
35
December 2020
December 2020   (Final data collection date for primary outcome measure)

Inclusion Criteria:

i)Life expectancy greater than 2 years ii) Suitable arterial anatomy iii) Absence of systemic disease or allergy that precludes an endovascular repair iv) Capable of giving informed consent and willingness to comply with follow up schedule v) Patient is considered high or prohibitive risk for open surgical repair of the ascending aneurysm or dissection

Exclusion Criteria:

Patient excluded if ANY of the following are true:

i) Pregnancy ii) History of anaphylactic reaction to contrast material with an inability to properly prophylax the patient appropriately iii) Allergy to stainless steel or polyester (allergy to stainless steel is not relevant if the Low Profile device is to be used) iv) Unwilling to comply with follow up schedule v) Serious or systemic groin infection vi) An uncorrectable coagulopathy

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact: Yuki Kuramochi, RN, BSN 216-445-4063 kuramoy@ccf.org
United States
 
 
NCT00583817
G000101
IRB 3917 ( Other Identifier: Cleveland Clinic IRB )
Yes
Not Provided
No
Not Provided
Matthew Eagleton, The Cleveland Clinic
Matthew Eagleton
The Cleveland Clinic
Principal Investigator: Matthew J Eagleton, MD The Cleveland Clinic
The Cleveland Clinic
April 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP